Lynnette C Fallon Axcelis Technologies Inc (ACLS) insider trading activity

Lynnette C Fallon is EXECUTIVE VP, HR/LEGAL AND GEN of AXCELIS TECHNOLOGIES INC. Currently has a direct ownership of 30,406 shares of ACLS, which is worth approximately $2.35 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 272 shares (Common Stock) at a price of $111.29 per share, resulting in proceeds of $30,270. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.4K

0% 3M change

3.08% 12M change

Total Value Held $2.35 Million

LYNNETTE C FALLON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2024	SELL Payment of exercise price or tax liability	$30,270 $111.29 p/Share	272 Reduced 0.89%	30,406 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$98,736 $113.23 p/Share	872 Reduced 2.76%	30,678 Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$71,321 $113.57 p/Share	628 Reduced 1.95%	31,550 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$148,741 $112.94 p/Share	1,317 Reduced 3.93%	32,178 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	3,200 Added 8.72%	33,495 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	-	1,659 Reduced 5.19%	30,295 Common Stock
Dec 14 2023	SELL Bona fide gift	-	365 Reduced 1.16%	31,006 Common Stock
Sep 07 2023	SELL Open market or private sale	$561,729 $181.32 p/Share	3,098 Reduced 8.99%	31,371 Common Stock
Jun 07 2023	SELL Open market or private sale	$273,604 $172.73 p/Share	1,584 Reduced 4.39%	34,469 Common Stock
May 25 2023	SELL Open market or private sale	$286,288 $152.2 p/Share	1,881 Reduced 4.96%	36,053 Common Stock
May 18 2023	SELL Open market or private sale	$341,135 $141.55 p/Share	2,410 Reduced 5.97%	37,934 Common Stock
May 17 2023	SELL Payment of exercise price or tax liability	$120,065 $137.69 p/Share	872 Reduced 2.12%	40,344 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$81,589 $129.92 p/Share	628 Reduced 1.5%	41,216 Common Stock
May 16 2023	SELL Open market or private sale	$534,940 $129.84 p/Share	4,120 Reduced 8.96%	41,844 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$316,391 $127.99 p/Share	2,472 Reduced 5.1%	45,964 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	5,400 Added 10.03%	48,436 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	-	5,595 Reduced 11.51%	43,036 Common Stock
Feb 13 2023	SELL Open market or private sale	$450,802 $127.67 p/Share	3,531 Reduced 7.39%	44,239 Common Stock
Nov 15 2022	SELL Open market or private sale	$281,477 $79.0 p/Share	3,563 Reduced 6.94%	47,770 Common Stock
Aug 12 2022	SELL Open market or private sale	$285,918 $75.5 p/Share	3,787 Reduced 6.87%	51,333 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$52,808 $60.56 p/Share	872 Reduced 1.56%	55,120 Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$47,472 $56.38 p/Share	842 Reduced 1.85%	44,664 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	11,328 Added 16.83%	55,992 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$139,315 $56.38 p/Share	2,471 Reduced 5.15%	45,506 Common Stock
Mar 17 2022	SELL Open market or private sale	$233,441 $71.85 p/Share	3,249 Reduced 6.34%	47,977 Common Stock

Also insider at

CLPT

ClearPoint Neuro, Inc. Healthcare

Director

LCF